The microenvironment in mature B-cell malignancies: a target for new treatment strategies

Jan A. Burger(The University of Texas MD Anderson Cancer Center), Federico Caligaris‐Cappio(Vita-Salute San Raffaele University)

Blood

July 28, 2009

10.1182/blood-2009-06-225326

Cited by 576

Related Papers

Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute–Working Group 1996 guidelines

|Blood|2008|3.2k

Targeting BTK with Ibrutinib in Relapsed Chronic Lymphocytic Leukemia

|New England Journal of Medicine|2013|2.2k

iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL

|Blood|2018|1.7k

Ibrutinib versus Ofatumumab in Previously Treated Chronic Lymphoid Leukemia

|New England Journal of Medicine|2014|1.6k

Ibrutinib as Initial Therapy for Patients with Chronic Lymphocytic Leukemia

|New England Journal of Medicine|2015|1.6k